Valuation: Celltrion, Inc.

Capitalization 39,821B 28.67B 24.6B 22.92B 21.33B 39.35B 2,470B 43.94B 277B 105B 1,158B 108B 105B 4,256B P/E ratio 2025 *
47x
P/E ratio 2026 * 32.7x
Enterprise value 41.21B 29.67M 25.46M 23.72M 22.07M 40.72M 2.56B 45.47M 287M 108M 1.2B 111M 109M 4.4B EV / Sales 2025 *
9.52x
EV / Sales 2026 * 7.76x
Free-Float
70.87%
Yield 2025 *
0.4%
Yield 2026 * 0.37%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.06%
1 week+0.95%
Current month+12.97%
1 month+11.09%
3 months+19.13%
6 months+4.17%
Current year+0.01%
More quotes
1 week 174,700
Extreme 174700
182,000
1 month 158,400
Extreme 158400
182,000
Current year 144,615.38
Extreme 144615.3846
185,480.77
1 year 144,615.38
Extreme 144615.3846
193,223.44
3 years 119,963.37
Extreme 119963.37
220,695.97
5 years 119,963.37
Extreme 119963.37
341,497.26
10 years 43,984.12
Extreme 43984.1176
341,497.26
More quotes
Manager TitleAgeSince
Chief Executive Officer - 20/03/2015
Director of Finance/CFO 50 -
Compliance Officer 43 -
Director TitleAgeSince
Chairman 67 -
Director/Board Member 66 17/07/2008
Director/Board Member 67 17/07/2008
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.06%+0.95%+4.78%+11.89% 28.67B
-0.04%+1.03%+10.09%+1.28% 50.35B
+1.45%+17.68%+90.35%+65.14% 34.95B
-1.60%-1.33%-28.47%-27.15% 27.79B
+1.19%+1.25%+26.23%-21.75% 12.81B
-2.27%-4.64%-56.46%-32.78% 11.41B
+0.54%+7.21%+47.29% - 10.56B
+0.25%+0.48%+13.16%-3.05% 10.47B
-4.12%-2.89%+25.66%+93.20% 10.29B
-2.28%-3.60%-25.98%+101.52% 8.96B
Average -0.69%+1.70%+10.66%+20.92% 20.63B
Weighted average by Cap. -0.30%+3.24%+16.35%+15.90%
See all sector performances

Financials

2025 *2026 *
Net sales 4,330B 3.12B 2.68B 2.49B 2.32B 4.28B 269B 4.78B 30.12B 11.37B 126B 11.7B 11.45B 463B 5,207B 3.75B 3.22B 3B 2.79B 5.15B 323B 5.75B 36.21B 13.67B 151B 14.06B 13.77B 557B
Net income 872B 628M 539M 502M 467M 862M 54.08B 962M 6.06B 2.29B 25.36B 2.36B 2.31B 93.21B 1,269B 914M 784M 731M 680M 1.25B 78.71B 1.4B 8.83B 3.33B 36.9B 3.43B 3.36B 136B
Net Debt 1,389B 1B 858M 800M 744M 1.37B 86.17B 1.53B 9.66B 3.65B 40.4B 3.75B 3.68B 149B 585B 421M 361M 336M 313M 578M 36.25B 645M 4.07B 1.53B 17B 1.58B 1.55B 62.48B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,391
More about the company
Date Price Change Volume
18/07/25 180,300.00 -0.06% 257,912
17/07/25 180,400.00 +2.04% 648,817
16/07/25 176,800.00 -1.01% 264,941
15/07/25 178,600.00 +0.90% 307,806
14/07/25 177,000.00 -0.90% 353,485

End-of-day quote Korea S.E., 18 July 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
180,300.00KRW
Average target price
215,992.16KRW
Spread / Average Target
+19.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock